Drug
Dexlansoprazole
Dexlansoprazole: highest development phase Approved, developed by Takeda, Viatris. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Takeda, Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| DEXLANSOPRAZOLE | Approved | |
| Dexlansoprazole NCT02162758 | Phase 2 | Barrett's Esophagus |
| Dexlansoprazole NCT01642602 | Phase 2 | Gastroesophageal Reflux Disease |
Latest
Follow Dexlansoprazole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.